NCEH-1 modulates cholesterol metabolism and protects against &agr;-synuclein toxicity in a C. elegans model of Parkinson’s disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Human Molecular Genetics

• Publication date

  2017-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddx269PMID 28934392PMCID PMC5886139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity

  2025cited by this paper
• Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: An updated mini-review

  2017cited by this paper
• Mitochondrial lipids in neurodegeneration

  2016cited by this paper
• 2015 Update on Parkinson disease

  2015cited by this paper
• Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants

  2015cited by this paper
• Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism

  2015cited by this paper
• Cholesterol metabolism and homeostasis in the brain

  2015cited by this paper
• Tissue-based map of the human proteome

  2015cited by this paper
• Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?

  2015cited by this paper
• In vitro γ-ray-induced inflammatory response is dominated by culturing conditions rather than radiation exposures

  2015cited by this paper
• RTCB-1 Mediates Neuroprotection via XBP-1 mRNA Splicing in the Unfolded Protein Response Pathway

  2014cited by this paper
• Phosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson disease

  2014cited by this paper
• Caenorhabditis elegans glia modulate neuronal activity and behavior

  2014cited by this paper
• The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.

  2014cited by this paper
• Alpha-Synuclein Function and Dysfunction on Cellular Membranes

  2014cited by this paper
• Assessing aging and senescent decline in Caenorhabditis elegans: cohort survival analysis.

  2013cited by this paper
• Role of Serum Cholesterol in Parkinson's Disease: A Meta-Analysis of Evidence

  2013cited by this paper
• High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice.

  2012cited by this paper
• Developmental milestones punctuate gene expression in the Caenorhabditis embryo.

  2012cited by this paper
• Functional Analysis of VPS41-Mediated Neuroprotection in Caenorhabditis elegans and Mammalian Models of Parkinson's Disease

  2012cited by this paper
• Estrogen-dependent activation of neutral cholesterol ester hydrolase underlying gender difference of atherogenesis in apoE-/- mice.

  2011cited by this paper
• The fusogenic tilted peptide (67-78) of α-synuclein is a cholesterol binding domain.

  2011cited by this paper
• Lack of association of dairy food, calcium, and vitamin D intake with the risk of Parkinson's disease: a case-control study in Japan.

  2011cited by this paper
• The mevalonate pathway in C. Elegans

  2011cited by this paper
• The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response.

  2010cited by this paper
• Targeting of neutral cholesterol ester hydrolase to the endoplasmic reticulum via its N-terminal sequence[S]

  2010influential reference
• The Critical Role of Neutral Cholesterol Ester Hydrolase 1 in Cholesterol Removal From Human Macrophages

  2010cited by this paper
• Diabetes and insulin in regulation of brain cholesterol metabolism.

  2010cited by this paper
• Pharmacogenetic Analysis Reveals a Post-Developmental Role for Rac GTPases in Caenorhabditis elegans GABAergic Neurotransmission

  2009cited by this paper
• Altered Cholesterol Ester Cycle in Skin Fibroblasts from Patients with Alzheimer's Disease

  2009cited by this paper
• Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis.

  2009cited by this paper
• Total cholesterol and the risk of Parkinson disease

  2008cited by this paper
• Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model

  2008cited by this paper
• Identification of Neutral Cholesterol Ester Hydrolase, a Key Enzyme Removing Cholesterol from Macrophages*

  2008cited by this paper
• The insulin paradox: aging, proteotoxicity and neurodegeneration

  2008cited by this paper
• Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress.

  2007cited by this paper
• Stable overexpression of human macrophage cholesteryl ester hydrolase results in enhanced free cholesterol efflux from human THP1 macrophages.

  2007cited by this paper
• Epidemiology of Parkinson's disease.

  2006cited by this paper
• Cholesterol sensing, trafficking, and esterification.

  2006cited by this paper
• An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling.

  2006cited by this paper
• Nonvesicular sterol movement from plasma membrane to ER requires oxysterol-binding protein–related proteins and phosphoinositides

  2006cited by this paper
• α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models

  2006cited by this paper
• Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate α-synuclein fibrilization

  2006cited by this paper
• Torsin-Mediated Protection from Cellular Stress in the Dopaminergic Neurons of Caenorhabditis elegans

  2005cited by this paper
• Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen.

  2004cited by this paper
• Brain Cholesterol: Long Secret Life Behind a Barrier

  2004cited by this paper
• Intracellular Cholesterol Transport

  2004cited by this paper
• Distinct Endosomal Compartments in Early Trafficking of Low Density Lipoprotein-derived Cholesterol*

  2003cited by this paper
• Genome-wide RNAi screening in Caenorhabditis elegans.

  2003cited by this paper
• Importance of different pathways of cellular cholesterol efflux.

  2003cited by this paper
• Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans

  2003cited by this paper
• Lipid binding inhibits alpha-synuclein fibril formation.

  2003cited by this paper
• Consequences of cellular cholesterol accumulation: basic concepts and physiological implications.

  2002cited by this paper
• The neurodegeneration mutant löchrig interferes with cholesterol homeostasis and Appl processing

  2002cited by this paper
• Liver X receptors in the central nervous system: From lipid homeostasis to neuronal degeneration

  2002cited by this paper
• CNS synaptogenesis promoted by glia-derived cholesterol.

  2001cited by this paper
• C. elegans : a practical approach

  1999cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper
• Evidence for a Cholesterol Transport Pathway from Lysosomes to Endoplasmic Reticulum That Is Independent of the Plasma Membrane*

  1998cited by this paper
• Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages.

  1996cited by this paper
• Cellular biochemistry of oxysterols derived from the diet or oxidation in vivo

  1996cited by this paper
• A C. elegans mutant that lives twice as long as wild type

  1993cited by this paper
• Serine-to-alanine substitutions at the amino-terminal region of phytochrome A result in an increase in biological activity.

  1992cited by this paper
• [Genetics of Caenorhabditis elegans].

  1989cited by this paper
• Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect.

  1985cited by this paper
• The genetics of Caenorhabditis elegans.

  1974cited by this paper

• Mitochondrial dysfunction and disrupted neuronal lipid homeostasis in Parkinson's disease: Potential mechanisms and therapeutic implications.

  2026cites this paper
• Core fucosylation of NCEH1 by FUT8 promotes progression of high-grade serous ovarian cancer by driving tumor-associated macrophage M2 polarization.

  2026cites this paper
• 6-PPD quinone reduces lifespan by activating a feedback loop between cholesterol transformation related signal and insulin signaling in C. elegans

  2025cites this paper
• Diabetic encephalopathy models: A systematic review from cells to animals.

  2025cites this paper
• Environmentally relevant concentrations of 6-PPDQ disrupt vitamin D3 adsorption and receptor function in Caenorhabditis elegans.

  2025cites this paper
• Ubiquitin Proteasome System Components, RAD23A and USP13, Modulate TDP-43 Solubility and Neuronal Toxicity

  2025cites this paper
• Visualize neuronal membrane cholesterol with split-fluorescent protein tagged YDQA sensor

  2025cites this paper
• STAG2-truncating variants reveal a mosaic STAG2 inactivation pattern and compensatory mechanisms involving cohesin complex remodeling

  2025cites this paper
• Circadian rhythm disruptions associated with opioid use disorder in synaptic proteomes of human dorsolateral prefrontal cortex and nucleus accumbens

  2023cites this paper
• Construction and Mechanism of IL‐15‐Based Coactivated Polymeric Micelles for NK Cell Immunotherapy

  2023cites this paper
• Apolipoprotein E ε4 triggers neurotoxicity via cholesterol accumulation, acetylcholine dyshomeostasis, and PKCε mislocalization in cholinergic neuronal cells.

  2023cites this paper
• Genetic modifiers of synucleinopathies—lessons from experimental models

  2023cites this paper
• Redox modulation of stress resilience by Crocus Sativus L. for potential neuroprotective and anti-neuroinflammatory applications in brain disorders: From molecular basis to therapy.

  2022cites this paper
• KIAA1363—A Multifunctional Enzyme in Xenobiotic Detoxification and Lipid Ester Hydrolysis

  2022cites this paper
• Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson’s disease models

  2022cites this paper
• Lipid metabolism and ageing in Caenorhabditis elegans: a complex interplay

  2022cites this paper
• A multi-omics study to characterize the transdifferentiation of human dermal fibroblasts to osteoblast-like cells

  2022cites this paper
• Alteration in the cerebrospinal fluid lipidome in Parkinson´s disease: A pilot study

  2021cites this paper
• Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths

  2021cites this paper
• Connecting Cholesterol Efflux Factors to Lung Cancer Biology and Therapeutics

  2021cites this paper
• Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study

  2021cites this paper
• Association of lipid levels with motor and cognitive function and decline in advanced Parkinson's disease in the Mark-PD study.

  2021cites this paper
• Probiotic Bacillus subtilis Protects against α-Synuclein Aggregation in C. elegans

  2020cites this paper
• Blood brain barrier inflammation and potential therapeutic role of phytochemicals

  2020cites this paper
• Alpha-synuclein spreading pathology in Parkinson's disease: the influence of iron and the Rho-kinase inhibitor fasudil

  2020cites this paper
• Modeling neurodegeneration in Caenorhabditis elegans

  2020cites this paper
• Cholesterol Regulates Innate Immunity via Nuclear Hormone Receptor NHR-8

  2020cites this paper
• Cholesterol-binding protein TSPO2 coordinates maturation and proliferation of terminally differentiating erythroblasts

  2020cites this paper
• Alpha-Synuclein Aggregation, Cholesterol Transport, and the 18-kDa Translocator Protein

  2019cites this paper
• The Role of Lipids in Parkinson’s Disease

  2019cites this paper
• Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain

  2018cites this paper
• Intracellular Cholesterol Trafficking and Impact in Neurodegeneration

  2017cites this paper
• Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.

  2017cites this paper